Home
Iovance Biotherapeutics IOVA spent $260K on lobbying in Q4 2022 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $260,000
- Quarter
- Q4 2022
- Client
- Iovance Biotherapeutics
- Reported
- 23/01/20
$360K on lobbying in 2022
What else happened in Iovance Biotherapeutics around then
Filed or reported within 30 days of the trade day · 22/12/01~23/01/30Iovance Biotherapeutics's other lobbying reports
- Iovance Biotherapeutics
LobbyingIovance Biotherapeutics
LobbyingIovance Biotherapeutics
IOVA
Under $5,000
Under $5,000
Reported 23/07/20
for Q2 2023
- Iovance Biotherapeutics
LobbyingIovance Biotherapeutics
LobbyingIovance Biotherapeutics
IOVA
Under $5,000
Under $5,000
Reported 23/07/20
for Q2 2023
- Iovance Biotherapeutics
LobbyingIovance Biotherapeutics
LobbyingIovance Biotherapeutics
IOVA
Under $5,000
Under $5,000
Reported 23/04/20
for Q1 2023
- Iovance Biotherapeutics
LobbyingIovance Biotherapeutics
LobbyingIovance Biotherapeutics
IOVA
Under $5,000
Under $5,000
Reported 23/04/20
for Q1 2023
- Iovance Biotherapeutics
LobbyingIovance Biotherapeutics
LobbyingIovance Biotherapeutics
IOVA
$170K
$170K
Reported 23/03/14
for Q1 2023